You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 6,005,167


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,005,167
Title: Male-sterile plants, method for obtaining male-sterile plants and recombinant DNA for use therein
Abstract:The present invention provides male-sterile plants. The plants have a recombinant polynucleotide integrated into their genome, essentially comprising an inhibitory gene, which, upon proper expression in the anthers of the plant, is capable of inhibiting expression of one or more genes encoding an enzyme involved in the synthesis of chalcone, or one of its precursors.
Inventor(s): Van Tunen; Adrianus Johannes (Wageningen, NL), Van Der Meer; Ingrid Maria (Amsterdam, NL), Mol; Josephus Nicolaas Maria (Badhoevedorp, NL)
Assignee: Mogen International N.V. (Leiden, NL)
Application Number:08/137,024
Patent Claims:1. A polynucleotide which can be directed against a target gene of a plant having reproductive organs which render the plant both male-fertile and female-fertile, said plant having a biosynthesis pathway wherein there is produced a plurality of enzymes which catalyze a stepwise synthesis of chalcone, said target gene encoding one enzyme of the chalcone biosynthesis pathway, said polynucleotide comprising:

a) an inhibitory gene encoding an RNA molecule or polypeptide which, when produced in said plant at a sufficient level, inhibits expression of said one enzyme sufficiently to render the plant male-sterile without impairing the female-fertility of the plant; and

b) a promotor operably linked to said inhibitory gene, said promotor being sufficiently active in anthers of the plant to promote expression of said RNA molecule or polypeptide in the anthers of the plant at said sufficient level.

2. A polynucleotide as claimed in claim 1 wherein the polynucleotide is a hybrid molecule that is formed by an in vitro combination of DNA from a plurality of different molecules.

3. A polynucleotide as claimed in claim 2 wherein the inhibitory gene encodes an RNA molecule that is sufficiently complementary to and capable of hybridizing with an RNA molecule produced by said target gene so as to inhibit expression of said one enzyme.

4. A polynucleotide as claimed in claim 2 wherein the inhibitory gene encodes an RNA molecule which is substantially identical to an RNA molecule produced by said target gene whereby it inhibits expression of said one enzyme by co-suppression.

5. A plant genome, comprising incorporated therein a polynucleotide according to claim 1.

6. A method for rendering a plant incapable of producing functional pollen, said method comprising inhibiting the synthesis of chalcone in cells of an anther of the plant, including cells of a tapetum layer of the anther, by a) transforming the plant with an inhibitory gene that encodes a nucleotide transcript that inhibits expression of a target gene, said target gene encoding a nucleotide transcript for an enzyme of the chalcone biosynthesis pathway, the transcript encoded by the inhibitory gene being sufficiently similar or sufficiently complementary to the transcript encoded by the target gene to inhibit the expression of the target gene by antisense inhibition or cosuppression, said inhibitory gene being under the control of a promoter that causes selective expression of the gene in the anther of the plant including the cells of the tapetum layer, such that expression of the gene renders the plant incapable of producing functional pollen but is not lethal to the plant; and b) regenerating the plant.

7. A method as claimed in claim 6 wherein said enzyme is chalcone synthase (CHS; E.C. 2.3.1.74).

8. A polynucleotide according to claim 3, wherein the target gene encodes chalcone synthase.

9. A polynucleotide according to claim 1 wherein said one enzyme is selected from the group consisting of cinnamate 4-hydroxylase (C4H; E.C. 1.14.13.11), 4-coumaroyl-CoA ligase (4CL; E.C. 6.2.1.12), and chalcone synthase (CHS; E.C.2.3.1.74).

10. A method for obtaining a male-sterile plant, comprising the steps of

(a) transferring a polynucleotide according to claim 1 to cells of a male-fertile plant,

(b) generating whole new plants from cells having incorporated said polynucleotide, and

(c) selecting a plant that is male-sterile.

11. A plant cell comprising the plant genome of claim 5.

12. A male-sterile plant comprising the plant genome of claim 5.

13. A method for obtaining seed of the male-sterile plant according to claim 12, comprising the steps of:

(a) contacting the pistil of a male-sterile plant with pollen of the same male-sterile plant in the presence of a suitable flavonoid compound, and

(b) allowing the pollen to germinate on the pistil and fertilize the male-sterile plant, and

(c) allowing the plant to set seed.

14. A method according to claim 13, wherein the pollen are suspended in a suitable pollen medium comprising a flavonoid compound selected from the group consisting of myricetin, quercetin and kaempferol, within a concentration range of 100 nm to 3 .mu.M prior to contacting the pistil of a male sterile plant with the pollen.

15. A method according to claim 14, wherein the pollen medium has the following composition: 100 mg/l H.sub.3 BO.sub.3 300 mg/l CaNO.sub.3, 200 mg/l MgSO.sub.4, 100 mg/l KNO.sub.3, 12.5% sucrose in sterile water.

16. Seed obtained by using a method according to claim 13, said seed containing said plant genome.

17. A homozygous male-sterile plant obtainable from a seed according to claim 16.

18. A method for the production of heterozygous male-sterile plants by fertilising a homozygous male-sterile plant according to claim 17 with a male-fertile plant, harvesting the seed and growing heterozygous male-sterile plants from said seed.

19. A method for obtaining hybrid seed comprising the steps of crossing a male-sterile plant from claim 12 with a male-fertile plant and collecting the hybrid seed.

20. The hybrid seed obtained by the method according to claim 19.

21. A male-sterile plant produced by the method of claim 6.

22. A method as claimed in claim 6, wherein the inhibitory gene is an antisense gene directed against the target gene.

23. A method for obtaining seed of a male-sterile plant comprising the steps of:

a) obtaining a male-sterile plant by transforming a male-fertile plant with a DNA construct comprising a promoter that will promote expression in the anthers of the plant that is operably linked to a chalcone synthase gene, or a portion of said gene that is sufficient to inhibit the expression of chalcone synthase in the plant, and

b) contacting the pistil of said male-sterile plant with pollen of the same male-sterile plant in the presence of a flavonoid compound selected from the group consisting of myricetin, quercetin and kaempferol, and

c) allowing the pollen to germinate on the pistil and fertilize the male-sterile plant, and

d) allowing the plant to set seed.

24. A DNA construct for use in transforming a male-fertile plant, said construct comprising a promoter that will promote expression in the anthers of the male-fertile plant, said promoter being operably linked to an inhibitory gene that is a) a chalcone synthase gene, or a portion of the chalcone synthase gene that is sufficient to inhibit the expression of chalcone synthase in the plant, or b) an antisense gene that is sufficiently complementary to a native gene in the male-fertile plant that encodes chalcone synthase to inhibit the expression of chalcone synthase in the male-fertile plant, said construct being a hybrid molecule that is not naturally present in said male-fertile plant.

25. A DNA construct as claimed in claim 24 wherein the inhibitory gene is the chalcone synthase gene or the portion of the chalcone synthase gene.

26. A method for obtaining a male-sterile plant, comprising the steps of:

a) transferring the construct of claim 25 to a cell of a male-fertile plant so that the construct is incorporated into the genome of the cell, and

b) generating a new plant from the cell having said construct incorporated into its genome.

27. A method for obtaining seed from the male-sterile plant of claim 26 comprising the steps of:

i) contacting the pistil of the male-sterile plant with pollen of the same male-sterile plant in the presence of a flavonoid compound selected from the group consisting of myricetin, quercetin, and kaempferol,

ii) allowing the pollen to germinate on the pistil,

iii) allowing the plant to set seed, and

iv) collecting the seed.

28. A DNA construct as claimed in claim 24 wherein the inhibitory gene is the antisense gene.

29. A method for obtaining a male-sterile plant, comprising the steps of:

a) transferring the construct of claim 28 to a cell of a male-fertile plant so that the construct is incorporated into the genome of the cell, and

b) generating a new plant from the cell having said construct incorporated into its genome.

30. A method for obtaining seed from the male-sterile plant of claim 29 comprising the steps of:

i) contacting the pistil of the male-sterile plant with pollen of the same male-sterile plant in the presence of a flavonoid compound selected from the group consisting of myricetin, quercetin, and kaempferol,

ii) allowing the pollen to germinate on the pistil,

iii) allowing the plant to set seed, and

iv) collecting the seed.

31. A method as claimed in claim 30 wherein the promoter is a hybrid promoter comprising an anther box from a CHS-A gene of Petunia hybrida fused to a CaMV 35S promoter.

32. A method as claimed in claim 27, wherein the promoter is a hybrid promoter comprising an anther box from a CHS-A gene of Petunia hybrida fused to a CaMV 35S promoter.

33. A method as claimed in claim 7, wherein the promoter is a hybrid promoter comprising an anther box from a CHS-A gene of Petunia hybrida fused to a CaMV 35S promoter.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.